Karen S.

Enthusiast
DISC Type : i

Director Board of Directors at Context Therapeutics

United States

Overview

Dr. Karen Smith is a C-suite biotech executive and board member with over 20 years of experience guiding companies through clinical development, regulatory approval, and M&A exits. She has contributed to over 20 product approvals, including Herceptin and Botox, and holds an MD, PhD, MBA, and an LLM.

Dr. Smith is a passionate and staunch advocate for women in science and a dedicated proponent for increasing diversity in the boardroom. Her leadership has been noted for shaping more inclusive corporate cultures.

She has guided multiple companies on whose boards she served to successful acquisitions, totaling nearly $20 billion in value.

Personality Overview

Consensus Focused

Optimistic

Amiable & Agreeable

They tend to be agreeable by nature, so take their promises with a pinch of salt.
  They are more about building relationships than just cutting deals. Unlike D or C types, they are convinced more by stories and testimonials.

Topics They Care About

Biotech M&A
Has a significant track record of serving on the boards of multiple companies that achieved successful exits through high-value acquisitions.
Clinical Development
Her career is built on deep expertise in clinical trial strategy and execution, having overseen more than 100 trials across numerous therapeutic areas.
Drug Commercialization
Has been a key contributor to bringing over 20 globally recognized drugs to market, including Vyxeos, Botox, and Abilify.

Media Appearances

Context Therapeutics Appoints Dr. Karen Smith and Dr. Luke Walker. Featured in Context Therapeutics Investor Relations

See Now

Work History

6-2024
Director Board of Directors at Context Therapeutics
6-2024
Director Board of Directors at Skye Bioscience Inc.
6-2018
Director Board of Directors at Sangamo Therapeutics, Inc.
10-2024
Principal and Co Founder at Boomerang Biopathways Pty Ltd
6-2018
Interim CMO or CEO. C-suite consultant, Board Member, Advisor. at Various Companies

Education

Doctor of Medicine (MD) from University of Warwick
PhD (combined with UCLA) from The University of Western Australia

More Information

Social Presence :

Prographics :

Exp : 7 Location : United States Job Level : Mid-senior Designation : Director Board of Directors at Context Therapeutics
URL has been copied!

Insights For Selling To Karen

During A Call Or A Meeting

DO's

  • Give them the opportunity to lead the conversation where possible
  • Ask them how their day is going or exchange some other pleasantries
  • Compliment them about their personality if you get a chance

DONT's

  • Don’t be excessively objective, be like a storyteller with them
  • Don’t push them for a direct ‘no’, take lack of ‘yes’ as ‘no’ after some time
  • Don't be critical or challenge them openly, they can react defensively

When Cold Calling

When Writing An Email

While Negotiating & Closing

    The secret to closing fast with Karen is

  • Relationships and rapport matter to them, but so does the value of the product.
  • Will you ever get a clear answer from Karen

  • They are unlikely to say no directly.

Insights For Deal Planning

    How fast (or slow) will Karen move?

  • They are not very fast decision makers, even while they continue to stay engaged.
  • Can Karen take some risk or not?

  • If it seems really necessary, they can take small risks.

You And Karen

Personality Compatibility


More Profiles

Discover additional public profiles from our index.

Search more profiles

Looking for someone else? Search here for anyone.

Or visit Humantic AI to know more.